The trademark application XPAT was filed by Amunix Pharmaceuticals, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on January 17, 2022, and it was registered by office on April 26, 2022 without any oppositions.
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 1 with following description of goods:
Chemicals used in the manufacture of pharmaceuticals
Reagents, enzymes, and nucleotides for scientific or medical research
Protein polymeric intermediates for use in the manufacture of pharmaceutical preparations
Biomedical compounds, namely, peptides, peptidomimetics, and protein polymeric intermediates used in the manufacture of pharmaceutical preparations.
The mark was filed in class 5 with following description of goods:
Pharmaceutical preparations for the treatment of cancerous and viral diseases
Pharmaceutical preparations for use in the field of oncology
Medical diagnostic reagents
Reagents for use in testing proteins for medical and diagnostic purposes.